Establishment and maintenance of vascular access in incident hemodialysis patients: a prospective cost analysis.

Despite the importance of hemodialysis vascular access, the cost of vascular access care has not been studied in detail. A prospective cost analysis was performed among incident hemodialysis patients to determine the cost of vascular access care overall and on the basis of access type. Detailed clinical and demographic information, as well as data on access type, was collected for all local incident hemodialysis patients between July 1, 1999, and November 1, 2001. A comprehensive measure of total vascular access costs, including surgery, radiology, hospitalization for access complications, physician costs, costs for management of outpatient bacteremia, and vascular access monitoring costs, was obtained. Costs are reported in 2002 Canadian dollars (1 CAN dollar = 0.69 US dollar). A total of 239 consecutive incident hemodialysis patients were identified, 49, 157, and 33 of whom were dialyzed exclusively with a catheter or had a native arteriovenous fistula or synthetic graft attempted, respectively. In year 1, 18.4% of all hospital admissions were for vascular access-related complications. The mean cost of all vascular access care in year 1 was 6890 CAN dollars(median 4020 dollars; interquartile range [IQR] 2440 dollars to 7540 dollars). The mean cost of access care per patient-year at risk for maintaining a catheter exclusively, attempting an arteriovenous fistula, or attempting a graft was 9180 dollars (median 3812 dollars; IQR 2250 dollars to 7762 dollars), 7989 dollars (median 4641 dollars ; IQR 3035 dollars to 8832 dollars), and 11,685 dollars (median 8152 dollars; IQR 3395 dollars to 12,908 dollars), respectively (P = 0.01). Vascular access care is responsible for a significant proportion of health care costs in the first year of hemodialysis. These results support clinical practice guidelines that recommend preferential placement of a native fistula.

[1]  K. Konner Vascular access in the 21st century. , 2002, Journal of nephrology.

[2]  K. Konner How to achieve a high rate (90%) of native arteriovenous fistulae. , 2002, Contributions to nephrology.

[3]  B. Charra,et al.  Long-Term Outcome of Permanent Hemodialysis Catheters: A Controlled Study , 2001, Blood Purification.

[4]  David W. Johnson,et al.  Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[5]  T. Hölzenbein,et al.  Strategies to Increase the Use of Autogenous Arteriovenous Fistula in End-Stage Renal Disease , 1997, Annals of vascular surgery.

[6]  L. Stitt,et al.  Regular monitoring of access flow compared with monitoring of venous pressure fails to improve graft survival. , 2003, Journal of the American Society of Nephrology : JASN.

[7]  M. Tonelli,et al.  Access flow monitoring of patients with native vessel arteriovenous fistulae and previous angioplasty. , 2002, Journal of the American Society of Nephrology : JASN.

[8]  B. Manns,et al.  The Southern Alberta Renal Program database: a prototype for patient management and research initiatives. , 2001, Clinical and investigative medicine. Medecine clinique et experimentale.

[9]  J. Éthier,et al.  Clinical practice guidelines for vascular access. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[10]  G. Nassar,et al.  Infectious complications of the hemodialysis access. , 2001, Kidney international.

[11]  H. Feldman,et al.  Hemodialysis vascular access morbidity. , 1996, Journal of the American Society of Nephrology : JASN.

[12]  D. Hirsch,et al.  Screening for subclinical stenosis in native vessel arteriovenous fistulae. , 2001, Journal of the American Society of Nephrology : JASN.

[13]  R. Wolfe,et al.  Vascular access use in Europe and the United States: results from the DOPPS. , 2002, Kidney international.

[14]  F. Port,et al.  Tailoring the initial vascular access for dialysis patients. , 2002, Kidney international.

[15]  G. Lipari,et al.  A prospective controlled trial on effect of percutaneous transluminal angioplasty on functioning arteriovenous fistulae survival. , 2003, Journal of the American Society of Nephrology : JASN.

[16]  Harold I Feldman,et al.  Predictors of successful arteriovenous fistula maturation. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[17]  S. Berceli,et al.  Prospective validation of an algorithm to maximize native arteriovenous fistulae for chronic hemodialysis access. , 2002, Journal of vascular surgery.

[18]  T A Ikizler,et al.  Vascular access blood flow monitoring reduces access morbidity and costs. , 2001, Kidney international.

[19]  Peter C Austin,et al.  A comparison of several regression models for analysing cost of CABG surgery , 2003, Statistics in medicine.

[20]  D. Churchill,et al.  Canadian Hemodialysis Morbidity Study. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[21]  Third Nkf-K Doqi III. NKF-K/DOQI Clinical Practice Guidelines for Vascular Access: update 2000. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.